SCHEMBL2885360

SCHEMBL2885360

CCOC(=O)c1c(Br)c(-c2ccc(F)cc2)n(-c2ccc(F)cc2)c1CBr

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM6 O15303 1/20 0.46
GABRA2 P47869 1/20 0.45
GABRB2 P47870 1/20 0.45
ALDH1A1 P00352 3/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CHRNA7 P36544 3/20 0.43
PRKCZ Q05513 1/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
HPGD P15428 2/20 0.42
GAA P10253 2/20 0.42
KDM4E B2RXH2 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA9 Q16790 1/20 0.42
LMNA P02545 3/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2880662 0.95 PDE4D (0.44) GRM6GABRA2GABRB2ALDH1A1NPSR1
SCHEMBL2884107 0.94 ALDH1A1 (0.46) GRM6GABRA2GABRB2ALDH1A1NPSR1
SCHEMBL2885359 0.83 GABRA2 (0.47) GABRA2GABRB2ALDH1A1KMT2AMEN1
SCHEMBL2880110 0.83 POLB (0.40) GRM6GABRA2GABRB2ALDH1A1NPSR1
SCHEMBL2886135 0.79 GRM6 (0.36) GRM6GABRA2GABRB2ALDH1A1NPSR1
SCHEMBL2882459 0.79 ALDH1A1 (0.46) GRM6GABRA2GABRB2ALDH1A1NPSR1
SCHEMBL2886551 0.78 KMT2A (0.40) GRM6GABRA2GABRB2ALDH1A1NPSR1
SCHEMBL2886141 0.78 GRM6 (0.38) GRM6GABRA2GABRB2ALDH1A1NPSR1
SCHEMBL2886828 0.76 ALDH1A1 (0.37) GRM6GABRA2GABRB2ALDH1A1NPSR1
SCHEMBL2882141 0.75 ALDH1A1 (0.36) GRM6ALDH1A1CHRNA7KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3124489-B1 THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN INC (US) 2020-07-15 EP disclosed
EP-3124489-A1 THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS Fibrogen, Inc. (US) 2017-02-01 EP disclosed
EP-2016078-B1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN INC (US) 2016-06-15 EP disclosed
US-7696223-B2 [(2-bromo-4-hydroxy-1-phenyl-1H-pyrrolo[2,3-c]pyridine-5-carbonyl)-amino]-acetic acid; modulates the stability and/or activity of hypoxia inducible factor (HIF) FIBROGEN, INC. (US) 2010-04-13 US disclosed
EP-2016078-A2 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN, INC. (US) 2009-01-21 EP disclosed
US-20080004309-A1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF FIBROGEN, INC. 2008-01-03 US disclosed
WO-2007115315-A2 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN, INC. (US) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004309-A1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF HIF1AN, HIF1A, EGLN2 GRM6 2689/4885GABRA2 2460/4885GABRB2 1903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.